{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:45:52Z","timestamp":1777574752577,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,11,22]],"date-time":"2016-11-22T00:00:00Z","timestamp":1479772800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Ankara T\u0131pl\u0131lar Vakf\u0131"},{"name":"Turkish Society of Rheumatology (RAED)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s10067-016-3483-7","type":"journal-article","created":{"date-parts":[[2016,11,22]],"date-time":"2016-11-22T16:23:48Z","timestamp":1479831828000},"page":"367-372","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Low serum fibroblast growth factor 2 levels not accompanied by increased serum pentraxin 3 levels in patients with systemic sclerosis"],"prefix":"10.1007","volume":"36","author":[{"given":"Ufuk","family":"\u0130lgen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00fc\u00e7teba Enes","family":"Yayla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nur\u015fen","family":"D\u00fczg\u00fcn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,22]]},"reference":[{"key":"3483_CR1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/978-1-4419-0901-5_7","volume":"653","author":"A Agrawal","year":"2009","unstructured":"Agrawal A, Singh PP, Bottazzi B, Garlanda C, Mantovani A (2009) Pattern recognition by pentraxins. Adv Exp Med Biol 653:98\u2013116","journal-title":"Adv Exp Med Biol"},{"issue":"32","key":"3483_CR2","doi-asserted-by":"publisher","first-page":"22605","DOI":"10.1074\/jbc.M601023200","volume":"281","author":"M Camozzi","year":"2006","unstructured":"Camozzi M, Rusnati M, Bugatti A, Bottazzi B, Mantovani A, Bastone A, Inforzato A, Vincenti S, Bracci L, Mastroianni D, Presta M (2006) Identification of an antiangiogenic FGF2-binding site in the N terminus of the soluble pattern recognition receptor PTX3. J Biol Chem 281(32):22605\u201322613. doi: 10.1074\/jbc.M601023200","journal-title":"J Biol Chem"},{"issue":"1","key":"3483_CR3","first-page":"90","volume":"24","author":"Y Ichiki","year":"1997","unstructured":"Ichiki Y, Smith EA, LeRoy EC, Trojanowska M (1997) Basic fibroblast growth factor inhibits basal and transforming growth factor-beta induced collagen alpha 2(I) gene expression in scleroderma and normal fibroblasts. J Rheumatol 24(1):90\u201395","journal-title":"J Rheumatol"},{"issue":"5","key":"3483_CR4","doi-asserted-by":"publisher","first-page":"380","DOI":"10.5505\/tjtes.2015.38839","volume":"21","author":"N Aksungur","year":"2015","unstructured":"Aksungur N, Ozogul B, Ozturk N, Arslan S, Karadeniz E, Korkut E, Gul MA, Kisaoglu A, Atamanalp SS (2015) Prognostic importance of pentraxin 3 levels in acute cholesistitis. Ulus Travma Acil Cerrahi Derg 21(5):380\u2013384. doi: 10.5505\/tjtes.2015.38839","journal-title":"Ulus Travma Acil Cerrahi Derg"},{"key":"3483_CR5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13054-016-1210-z","volume":"20","author":"MB Hansen","year":"2016","unstructured":"Hansen MB, Rasmussen LS, Garred P, Bidstrup D, Madsen MB, Hyldegaard O (2016) Pentraxin-3 as a marker of disease severity and risk of death in patients with necrotizing soft tissue infections: a nationwide, prospective, observational study. Crit Care 20:40. doi: 10.1186\/s13054-016-1210-z","journal-title":"Crit Care"},{"key":"3483_CR6","doi-asserted-by":"publisher","first-page":"421429","DOI":"10.1155\/2014\/421429","volume":"2014","author":"S Liu","year":"2014","unstructured":"Liu S, Qu X, Liu F, Wang C (2014) Pentraxin 3 as a prognostic biomarker in patients with systemic inflammation or infection. Mediat Inflamm 2014:421429. doi: 10.1155\/2014\/421429","journal-title":"Mediat Inflamm"},{"key":"3483_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jneuroim.2015.12.007","volume":"292","author":"I Rajkovic","year":"2016","unstructured":"Rajkovic I, Denes A, Allan SM, Pinteaux E (2016) Emerging roles of the acute phase protein pentraxin-3 during central nervous system disorders. J Neuroimmunol 292:27\u201333. doi: 10.1016\/j.jneuroim.2015.12.007","journal-title":"J Neuroimmunol"},{"issue":"7","key":"3483_CR8","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1177\/1352458512457845","volume":"19","author":"H Wang","year":"2013","unstructured":"Wang H, Wang K, Wang C, Zhong X, Qiu W, Hu X (2013) Increased plasma levels of pentraxin 3 in patients with multiple sclerosis and neuromyelitis optica. Mult Scler 19(7):926\u2013931. doi: 10.1177\/1352458512457845","journal-title":"Mult Scler"},{"issue":"3","key":"3483_CR9","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/eji.201545950","volume":"46","author":"K Ummenthum","year":"2016","unstructured":"Ummenthum K, Peferoen LA, Finardi A, Baker D, Pryce G, Mantovani A, Bsibsi M, Bottazzi B, Peferoen-Baert R, van der Valk P, Garlanda C, Kipp M, Furlan R, van Noort JM, Amor S (2016) Pentraxin-3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease. Eur J Immunol 46(3):701\u2013711. doi: 10.1002\/eji.201545950","journal-title":"Eur J Immunol"},{"issue":"6","key":"3483_CR10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1186\/s13075-014-0479-z","volume":"16","author":"E Tombetti","year":"2014","unstructured":"Tombetti E, Di Chio MC, Sartorelli S, Papa M, Salerno A, Bottazzi B, Bozzolo EP, Greco M, Rovere-Querini P, Baldissera E, Del Maschio A, Mantovani A, De Cobelli F, Sabbadini MG, Manfredi AA (2014) Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis. Arthritis Res Ther 16(6):479. doi: 10.1186\/s13075-014-0479-z","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"3483_CR11","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/art.33411","volume":"64","author":"M Baldini","year":"2012","unstructured":"Baldini M, Maugeri N, Ramirez GA, Giacomassi C, Castiglioni A, Prieto-Gonzalez S, Corbera-Bellalta M, Comite GD, Papa I, Dell'antonio G, Ammirati E, Cuccovillo I, Vecchio V, Mantovani A, Rovere-Querini P, Sabbadini MG, Cid MC, Manfredi AA (2012) Selective up-regulation of the soluble pattern-recognition receptor pentraxin 3 and of vascular endothelial growth factor in giant cell arteritis: relevance for recent optic nerve ischemia. Arthritis Rheum 64(3):854\u2013865. doi: 10.1002\/art.33411","journal-title":"Arthritis Rheum"},{"issue":"3","key":"3483_CR12","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1002\/art.21669","volume":"54","author":"AP Rossum van","year":"2006","unstructured":"van Rossum AP, Pas HH, Fazzini F, Huitema MG, Limburg PC, Jonkman MF, Kallenberg CG (2006) Abundance of the long pentraxin PTX3 at sites of leukocytoclastic lesions in patients with small-vessel vasculitis. Arthritis Rheum 54(3):986\u2013991. doi: 10.1002\/art.21669","journal-title":"Arthritis Rheum"},{"issue":"22","key":"3483_CR13","first-page":"3453","volume":"18","author":"S Uysal","year":"2014","unstructured":"Uysal S, Yilmaz FM, Karatoprak K, Artuz F, Cumbul NU (2014) The levels of serum pentraxin3, CRP, fetuin-A, and insulin in patients with psoriasis. Eur Rev Med Pharmacol Sci 18(22):3453\u20133458","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"3483_CR14","first-page":"137","volume":"39","author":"T Deniz","year":"2014","unstructured":"Deniz T, Kizilgul M, Uzunlulu M, Oguz A, Isbilen B (2014) Levels of pentraxin 3 and relationship with disease activity in patients with ankylosing spondylitis. Acta Reumatol Port 39(2):137\u2013142","journal-title":"Acta Reumatol Port"},{"issue":"1","key":"3483_CR15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1046\/j.1365-2249.2000.01110.x","volume":"119","author":"MM Luchetti","year":"2000","unstructured":"Luchetti MM, Piccinini G, Mantovani A, Peri G, Matteucci C, Pomponio G, Fratini M, Fraticelli P, Sambo P, Di Loreto C, Doni A, Introna M, Gabrielli A (2000) Expression and production of the long pentraxin PTX3 in rheumatoid arthritis (RA). Clin Exp Immunol 119(1):196\u2013202","journal-title":"Clin Exp Immunol"},{"key":"3483_CR16","doi-asserted-by":"publisher","first-page":"354014","DOI":"10.1155\/2015\/354014","volume":"2015","author":"R Assandri","year":"2015","unstructured":"Assandri R, Monari M, Colombo A, Dossi A, Montanelli A (2015) Pentraxin 3 plasma levels and disease activity in systemic lupus erythematosus. Autoimmune Dis 2015:354014. doi: 10.1155\/2015\/354014","journal-title":"Autoimmune Dis"},{"issue":"2","key":"3483_CR17","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s12016-015-8476-9","volume":"49","author":"N Bassi","year":"2015","unstructured":"Bassi N, Del Prete D, Ghirardello A, Gatto M, Ceol M, Zen M, Bettio S, Mantovani A, Iaccarino L, Punzi L, Doria A (2015) PTX3, anti-PTX3, and anti-C1q autoantibodies in lupus glomerulonephritis. Clin Rev Allergy Immunol 49(2):217\u2013226. doi: 10.1007\/s12016-015-8476-9","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"3483_CR18","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3109\/08916934.2014.983264","volume":"48","author":"P Cieslik","year":"2015","unstructured":"Cieslik P, Hrycek A (2015) Pentraxin 3 as a biomarker of local inflammatory response to vascular injury in systemic lupus erythematosus. Autoimmunity 48(4):242\u2013250. doi: 10.3109\/08916934.2014.983264","journal-title":"Autoimmunity"},{"issue":"3","key":"3483_CR19","doi-asserted-by":"publisher","first-page":"e2520","DOI":"10.1097\/MD.0000000000002520","volume":"95","author":"Y Pang","year":"2016","unstructured":"Pang Y, Tan Y, Li Y, Zhang J, Guo Y, Guo Z, Zhang C, Yu F, Zhao MH (2016) Pentraxin 3 is closely associated with tubulointerstitial injury in lupus nephritis: a large multicenter cross-sectional study. Medicine (Baltimore) 95(3):e2520. doi: 10.1097\/MD.0000000000002520","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"3483_CR20","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1186\/s13075-015-0879-8","volume":"17","author":"SS Pesickova","year":"2015","unstructured":"Pesickova SS, Rysava R, Lenicek M, Vitek L, Potlukova E, Hruskova Z, Jancova E, Honsova E, Zavada J, Trendelenburg M, Tesar V (2015) Prognostic value of anti-CRP antibodies in lupus nephritis in long-term follow-up. Arthritis Res Ther 17(1):371. doi: 10.1186\/s13075-015-0879-8","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"3483_CR21","doi-asserted-by":"publisher","first-page":"976","DOI":"10.3899\/jrheum.080343","volume":"36","author":"Y Iwata","year":"2009","unstructured":"Iwata Y, Yoshizaki A, Ogawa F, Komura K, Hara T, Muroi E, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Takehara K, Sato S (2009) Increased serum pentraxin 3 in patients with systemic sclerosis. J Rheumatol 36(5):976\u2013983. doi: 10.3899\/jrheum.080343","journal-title":"J Rheumatol"},{"issue":"2","key":"3483_CR22","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/art.38953","volume":"67","author":"Y Shirai","year":"2015","unstructured":"Shirai Y, Okazaki Y, Inoue Y, Tamura Y, Yasuoka H, Takeuchi T, Kuwana M (2015) Elevated levels of pentraxin 3 in systemic sclerosis: associations with vascular manifestations and defective vasculogenesis. Arthritis Rheumatol 67(2):498\u2013507. doi: 10.1002\/art.38953","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"3483_CR23","doi-asserted-by":"publisher","first-page":"e45834","DOI":"10.1371\/journal.pone.0045834","volume":"7","author":"Y Tamura","year":"2012","unstructured":"Tamura Y, Ono T, Kuwana M, Inoue K, Takei M, Yamamoto T, Kawakami T, Fujita J, Kataoka M, Kimura K, Sano M, Daida H, Satoh T, Fukuda K (2012) Human pentraxin 3 (PTX3) as a novel biomarker for the diagnosis of pulmonary arterial hypertension. PLoS One 7(9):e45834. doi: 10.1371\/journal.pone.0045834","journal-title":"PLoS One"},{"issue":"3","key":"3483_CR24","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.arcmed.2016.05.006","volume":"47","author":"XL Huang","year":"2016","unstructured":"Huang XL, Zhang L, Duan Y, Wang YJ, Wang J (2016) Association of pentraxin 3 with autoimmune diseases: a systematic review and meta-analysis. Arch Med Res 47(3):223\u2013231. doi: 10.1016\/j.arcmed.2016.05.006","journal-title":"Arch Med Res"},{"issue":"3 Pt 1","key":"3483_CR25","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0190-9622(96)90603-9","volume":"35","author":"T Kadono","year":"1996","unstructured":"Kadono T, Kikuchi K, Kubo M, Fujimoto M, Tamaki K (1996) Serum concentrations of basic fibroblast growth factor in collagen diseases. J Am Acad Dermatol 35(3 Pt 1):392\u2013397","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"3483_CR26","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1186\/ar596","volume":"4","author":"O Distler","year":"2002","unstructured":"Distler O, Del Rosso A, Giacomelli R, Cipriani P, Conforti ML, Guiducci S, Gay RE, Michel BA, Bruhlmann P, Muller-Ladner U, Gay S, Matucci-Cerinic M (2002) Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. Arthritis Res 4(6):R11","journal-title":"Arthritis Res"},{"issue":"3","key":"3483_CR27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/1523-1747.ep12286455","volume":"108","author":"CP Denton","year":"1997","unstructured":"Denton CP, Xu S, Black CM, Pearson JD (1997) Scleroderma fibroblasts show increased responsiveness to endothelial cell-derived IL-1 and bFGF. J Invest Dermatol 108(3):269\u2013274","journal-title":"J Invest Dermatol"},{"issue":"4","key":"3483_CR28","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/BF00414232","volume":"276","author":"K Nishioka","year":"1984","unstructured":"Nishioka K, Kobayashi Y, Katayama I, Sano S (1984) Reduced response of scleroderma fibroblasts to fibroblast growth factor. Arch Dermatol Res 276(4):224\u2013228","journal-title":"Arch Dermatol Res"},{"issue":"7","key":"3483_CR29","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/BF00371783","volume":"283","author":"K Takehara","year":"1991","unstructured":"Takehara K, Soma Y, Igarashi A, Kikuchi K, Moro A, Ishibashi Y (1991) Response of scleroderma fibroblasts to various growth factors. Arch Dermatol Res 283(7):461\u2013464","journal-title":"Arch Dermatol Res"},{"issue":"10","key":"3483_CR30","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.autrev.2011.04.019","volume":"10","author":"V Liakouli","year":"2011","unstructured":"Liakouli V, Cipriani P, Marrelli A, Alvaro S, Ruscitti P, Giacomelli R (2011) Angiogenic cytokines and growth factors in systemic sclerosis. Autoimmun Rev 10(10):590\u2013594. doi: 10.1016\/j.autrev.2011.04.019","journal-title":"Autoimmun Rev"},{"issue":"8","key":"3483_CR31","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1002\/art.27522","volume":"62","author":"F Margheri","year":"2010","unstructured":"Margheri F, Serrati S, Lapucci A, Chilla A, Bazzichi L, Bombardieri S, Kahaleh B, Calorini L, Bianchini F, Fibbi G, Del Rosso M (2010) Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12. Arthritis Rheum 62(8):2488\u20132498. doi: 10.1002\/art.27522","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3483_CR32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1182\/blood-2003-10-3433","volume":"104","author":"M Rusnati","year":"2004","unstructured":"Rusnati M, Camozzi M, Moroni E, Bottazzi B, Peri G, Indraccolo S, Amadori A, Mantovani A, Presta M (2004) Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis. Blood 104(1):92\u201399. doi: 10.1182\/blood-2003-10-3433","journal-title":"Blood"},{"issue":"6","key":"3483_CR33","first-page":"373","volume":"76","author":"K Yamanaka","year":"2005","unstructured":"Yamanaka K, Inaba T, Nomura E, Hurwitz D, Jones DA, Hakamada A, Isoda K, Kupper TS, Mizutani H (2005) Basic fibroblast growth factor treatment for skin ulcerations in scleroderma. Cutis 76(6):373\u2013376","journal-title":"Cutis"},{"issue":"11","key":"3483_CR34","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F Hoogen van den","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, Riemekasten G, Clements PJ, Denton CP, Distler O, Allanore Y, Furst DE, Gabrielli A, Mayes MD, van Laar JM, Seibold JR, Czirjak L, Steen VD, Inanc M, Kowal-Bielecka O, Muller-Ladner U, Valentini G, Veale DJ, Vonk MC, Walker UA, Chung L, Collier DH, Csuka ME, Fessler BJ, Guiducci S, Herrick A, Hsu VM, Jimenez S, Kahaleh B, Merkel PA, Sierakowski S, Silver RM, Simms RW, Varga J, Pope JE (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Arthritis Rheum 65(11):2737\u20132747. doi: 10.1002\/art.38098","journal-title":"Arthritis Rheum"},{"issue":"8","key":"3483_CR35","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace DJ, Nived O, Sturfelt G, Ramsey-Goldman R, Bae SC, Hanly JG, Sanchez-Guerrero J, Clarke A, Aranow C, Manzi S, Urowitz M, Gladman D, Kalunian K, Costner M, Werth VP, Zoma A, Bernatsky S, Ruiz-Irastorza G, Khamashta MA, Jacobsen S, Buyon JP, Maddison P, Dooley MA, van Vollenhoven RF, Ginzler E, Stoll T, Peschken C, Jorizzo JL, Callen JP, Lim SS, Fessler BJ, Inanc M, Kamen DL, Rahman A, Steinsson K, Franks AG Jr, Sigler L, Hameed S, Fang H, Pham N, Brey R, Weisman MH, McGwin G Jr, Magder LS (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64(8):2677\u20132686. doi: 10.1002\/art.34473","journal-title":"Arthritis Rheum"},{"issue":"2","key":"3483_CR36","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15(2):202\u2013205","journal-title":"J Rheumatol"},{"key":"3483_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2015.12.006","author":"WC Fan","year":"2016","unstructured":"Fan WC, Huang CC, Yang YY, Lin A, Lee KC, Hsieh YC, Fung CP, Hsu HC, Hou MC, Lin HC (2016) Serum pentraxin-3 and tumor necrosis factor-like weak inducer of apoptosis (TWEAK) predict severity of infections in acute decompensated cirrhotic patients. J Microbiol Immunol Infect. doi: 10.1016\/j.jmii.2015.12.006","journal-title":"J Microbiol Immunol Infect"},{"issue":"5","key":"3483_CR38","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/art.39033","volume":"67","author":"M Agilli","year":"2015","unstructured":"Agilli M, Ekinci S (2015) Assessment of elevated pentraxin 3 levels in systemic sclerosis: comment on the article by Shirai et al. Arthritis Rheumatol 67(5):1408\u20131409. doi: 10.1002\/art.39033","journal-title":"Arthritis Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3483-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-016-3483-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3483-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T04:12:40Z","timestamp":1498363960000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-016-3483-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,22]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["3483"],"URL":"https:\/\/doi.org\/10.1007\/s10067-016-3483-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,22]]}}}